Fundraising FoxGRA Venture — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups.
BiotechHealthtechMedical DevicesAtlanta, US
Mark Prausnitz(Director)inHenry Sebastien(Executive Vice President, Head of Technical Operations)Devin McAllister(Executive Vice President, Chief Technology Officer)inIdean Marvasty(Chief Financial Officer)Steve Damon(Chief Executive Officer)in
BoardBas Van Buijtenen(Director)
Co-investorsGlobal Health Investment CorporationJ2 VenturesGlobal Health Security
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.